Evidence map›Paper›PMID 41368512›Full record

ReviewJournal of hospice and palliative care2025

Palliative Care Integration in Oncology: A Review and Update.

Claire Wang, Thomas W LeBlanc

Abstract readReview
In one paragraph

Review in Journal of hospice and palliative care, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Claire WangDuke University School of Medicine, Durham, North Carolina, US.ORCID https://orcid.org/0009-0000-6543-9768
Thomas W LeBlancDuke Cancer Institute, Durham, North Carolina, US.ORCID https://orcid.org/0000-0002-0546-7895

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Palliative care (PC) is increasingly recognized as an essential component of high-quality cancer care, with evidence from randomized trials and meta-analyses demonstrating that it improves quality of life, mood, and goal-concordant end-of-life care. Despite these benefits, PC integration has been inconsistent, with many patients still receiving PC later in their disease course. Current models of integration include outpatient co-located PC clinics, inpatient consultation services, community- and home-based programs, and more recent innovations, such as telehealth and stepped approaches. These models have shown clear benefits; however, they are frequently organized by care settings rather than patient-specific needs, resulting in both underuse and inefficiency. Emerging evidence has begun to clarify the mechanisms through which PC provides patient benefits. Symptom control, coping support, longitudinal communication, and existential or spiritual interventions are among the active ingredients that are most consistently associated with improvements in patient outcomes. Recognition of these mechanistic drivers highlights the potential for precision PC, in which care is tailored to the unique drivers of each patient's needs. Implementation of precision PC requires embedding validated patient-reported outcomes and structured referral algorithms into oncology workflows, enabling real-time triage of targeted interventions. Interoperable technology, workforce expansion through the training of non-specialists, and policy reforms that support scalable delivery models, such as telehealth and nurse-led programs, will be essential for closing gaps in terms of access and equity. Precision PC offers a pragmatic framework for aligning limited resources with the diverse and evolving needs of patients with cancer, ensuring timely, individualized, and sustainable integration into modern oncology.

Indexed as

Coping skillsNeoplasmsPalliative carePatient reported outcome measuresPsychological stress

Identifiers

PMID41368512
PMCPMC12683178

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.